A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma

NCT03070964 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
14
Enrollment
INDUSTRY
Sponsor class

Stopped The main reason that motivated the study termination was the slow recruitment of the trial.

Conditions

Interventions

Sponsor

PharmaMar